HitGen, Inc. Hits Day High with 7.23% Surge Amid Market Decline

HitGen, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance today, gaining 7.23%. The stock reached an intraday high of CNY 36.90, showcasing its strong market activity. Over the past week, HitGen has demonstrated a robust performance with a 10.68% increase, and its one-month performance stands at an impressive 37.28%. Year-to-date, the stock has surged by 52.96%, significantly outperforming the China Shanghai Composite, which has only seen a 0.69% increase during the same period. The company's financial metrics reflect a positive trajectory, highlighted by a remarkable 114.98% growth in net profit reported on September 25. Additionally, HitGen's operating cash flow reached a record high of CNY 204.8 million, and its return on capital employed (ROCE) stands at 8.01%. With a market capitalization of CNY 10,782 million, HitGen continues to solidify its position as a reliable performer in the market.